LGMN and neoplasm: These properties may be mediated by increased extracellular matrix degradation, resulting from activation of zymogens such as progelatinase A. Legumain activates the gelatinase A zymogen, an important mediator of extracellular matrix degradation, and thus may be important for tumor cells to adapt a more invasive and metastatic phenotype [8].